Kim HD - Search Results

1

Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study.

Kim HD, Bang Y, Lee MA, Kim JW, Kim JH, Chon HJ, Kang B, Kang MJ, Kim I, Cheon J, Hwang JE, Kang JH, Byeon S, Hong JY, Ryoo BY, Lim HY, Yoo C. Kim HD, et al. Among authors: kim i, kim jw, kim jh. Liver Int. 2020 Oct;40(10):2544-2552. doi: 10.1111/liv.14573. Epub 2020 Jul 9. Liver Int. 2020. PMID: 32563213

2

Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.

Kim HD, Lim YS, Han S, An J, Kim GA, Kim SY, Lee SJ, Won HJ, Byun JH. Kim HD, et al. Among authors: kim sy, kim ga. Gastroenterology. 2015 Jun;148(7):1371-82. doi: 10.1053/j.gastro.2015.02.051. Epub 2015 Feb 28. Gastroenterology. 2015. PMID: 25733098

3

Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma.

Kim HD, An J, Kim JH, Gwon DI, Shin JH, Ko GY, Yoon HK, Sung KB, Kim KM, Lee HC. Kim HD, et al. Among authors: kim km, kim jh. J Vasc Interv Radiol. 2016 Apr;27(4):504-13. doi: 10.1016/j.jvir.2015.12.005. Epub 2016 Feb 16. J Vasc Interv Radiol. 2016. PMID: 26896049

4

Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.

Kim HD, Song GW, Shim JH, Han S, An J, Moon DB, Kim KM, Lim YS, Ko GY, Hwang S, Lee HC, Yu E, Sung KB, Lee SG. Kim HD, et al. Among authors: kim km. Hepatol Int. 2017 Mar;11(2):209-219. doi: 10.1007/s12072-017-9785-2. Epub 2017 Jan 31. Hepatol Int. 2017. PMID: 28144812

5

Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.

Kim JK, Kim HD, Jun MJ, Yun SC, Shim JH, Lee HC, Lee D, An J, Lim YS, Chung YH, Lee YS, Kim KM. Kim JK, et al. Among authors: kim km, kim hd. Dig Dis Sci. 2017 Oct;62(10):2923-2931. doi: 10.1007/s10620-017-4708-6. Epub 2017 Aug 16. Dig Dis Sci. 2017. PMID: 28815349

6

Association Between Expression Level of PD1 by Tumor-Infiltrating CD8⁺ T Cells and Features of Hepatocellular Carcinoma.

Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ, Yoo C, Yi K, Kim KH, Eo S, Moon DB, Hong SM, Ju YS, Shin EC, Hwang S, Park SH. Kim HD, et al. Among authors: kim mh, kim kh. Gastroenterology. 2018 Dec;155(6):1936-1950.e17. doi: 10.1053/j.gastro.2018.08.030. Epub 2018 Aug 24. Gastroenterology. 2018. PMID: 30145359

7

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.

Kim HD, Kim JH, Ryu YM, Kim D, Lee S, Shin J, Hong SM, Kim KH, Jung DH, Song GW, Hwang DW, Lee JH, Song KB, Ryoo BY, Jeong JH, Kim KP, Kim SY, Yoo C. Kim HD, et al. Among authors: kim d, kim kp, kim sy, kim kh, kim jh. Cancer Res Treat. 2021 Jan;53(1):162-171. doi: 10.4143/crt.2020.704. Epub 2020 Aug 31. Cancer Res Treat. 2021. PMID: 32878426 Free PMC article.

8

Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.

Casadei-Gardini A, Scartozzi M, Tada T, Yoo C, Shimose S, Masi G, Lonardi S, Frassineti LG, Nicola S, Piscaglia F, Kumada T, Kim HD, Koga H, Vivaldi C, Soldà C, Hiraoka A, Bang Y, Atsukawa M, Torimura T, Tsuj K, Itobayashi E, Toyoda H, Fukunishi S, Rimassa L, Rimini M, Cascinu S, Cucchetti A. Casadei-Gardini A, et al. Among authors: kim hd. Liver Int. 2021 Jun;41(6):1389-1397. doi: 10.1111/liv.14817. Epub 2021 Feb 20. Liver Int. 2021. PMID: 33547848

9

Implication of CD69⁺ CD103⁺ tissue-resident-like CD8⁺ T cells as a potential immunotherapeutic target for cholangiocarcinoma.

Kim HD, Jeong S, Park S, Lee YJ, Ju YS, Kim D, Song GW, Lee JH, Kim SY, Shin J, Shin EC, Hwang S, Yoo C, Park SH. Kim HD, et al. Among authors: kim d, kim sy. Liver Int. 2021 Apr;41(4):764-776. doi: 10.1111/liv.14814. Epub 2021 Feb 23. Liver Int. 2021. PMID: 33548061

10

Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.

Bang Y, Yoo C, Lonardi S, Kim HD, Vivaldi C, Rimini M, Frassineti GL, Park SR, Rizzato MD, Ryu MH, Salani F, Rapposelli IG, Ryoo BY, Zagonel V, Massa V, Valgiusti M, Burgio V, Scartozzi M, Cascinu S, Casadei-Gardini A. Bang Y, et al. Among authors: kim hd. Target Oncol. 2021 May;16(3):401-410. doi: 10.1007/s11523-021-00797-3. Epub 2021 Mar 1. Target Oncol. 2021. PMID: 33646487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,243 results

Search Page

Filters